Listing 1 - 10 of 10 |
Sort by
|
Choose an application
Total proctocolectomy followed by ileal pouch-anal anastomosis (IPAA) is currently the reference treatment in familial adenomatous polyposis (FAP) and ulcerative colitis (UC). At our institution, we always advocate the realization of an endoanal mucosectomy (EAM) followed by handsewn anastomosis at the level of the dentate line while other centers prefer a double-stapled anastomosis, invoking the superiority of this technique without EAM on functional results. The purpose of the present study is to evaluate the relevance of EAM considering functional results as well as control of neoplastic risk for patients treated at our institution since 1986.Methods. Medical records of 166 consecutive patients treated by IPAA for FAP (n = 57) or UC (n = 109) at our institution were reviewed. The data, which were specifically studied, include functional assessments at follow-up consultations, pathology of the EAM and findings made during the endoscopy monitoring of the ileal pouch. Results. The median stool frequency in our series of patients was 5,8 (IQR : 4,7-7,6) per 24h and 1,0 at n1ghttime (IQR : 0,5-1,8). 82% of patients had perfect daytime continence. 57% had perfect nighttime continence and 23% had less than one nighttime leakage per week. 76% of patients had less than one episode of urgency per week and 54% did not suffer from urgency at all. In patients with FAP, we found dysplasia or cancer on 73% of EAM specimens (94% of LGD, one in situ carcinoma and one invasive carcinoma). ln UC patients, only one EAM specimen showed LGD. None of our patients with FAP or RCUH was found to develop cancer in his pouch or anal canal after a median follow-up of 86 months (IQR :55-138) and 60 months (IQR : 25-102) respectively. ln patients with UC, endoscopy monitoring did not show any arousal of adenomas in the pouch. ln patients with FAP, 43% developed LGD after a median follow-up of 86 months (IQR : 60-128) and one patient (2,1%) showed HGD after 216 months of follow-up. Conclusions. Although we systematically perform an EAM in our patients, our functional results are as satisfying as the references we find in the literature, except with regards to nocturnal continence. However, the majority of patients who notice such an alteration do not mention more than one leakage per week. The high prevalence of dysplasia as well as the presence of two carcinomas on specimens from our patients with FAP are major reasons for conducting EAM in those patients. ln patients with RCUH, prevalence of dysplasia is much lower. The findings made during endoscopy monitoring are currently not putting any discredit on the efficiency of our EAMs. However, one should continue to perform this monitoring in order to keep an eye on the two distinct issues, which are the development of pouch dysplasia and the emergence of cancer on an islet of residual colonic mucosa. An influence of BMI on the development of adenomas in the ileal pouch was brought out and deserves further investigation. La coloproctectomie totale (CPT) suivie d'une anastomose iléo-anale (AIA) sur réservoir iléal est actuellement le traitement de référence de la polypose adénomateuse familiale (PAF) et de la rectocolite hémorragique (RCUH). Aux Cliniques universitaires Saint-Luc (CUSL), nous préconisons toujours la réalisation d'une mucosectomie endo-anale (MEA) suivie d'une anastomose manuelle à la ligne pectinée tandis que d’autres centres privilégient une anastomose mécanique à l’agrafeuse circulaire en invoquant une supériorité de cette technique sans MEA sur les résultats fonctionnels. L'objectif de cette étude est d'évaluer la pertinence de la MEA en mettant en balance les résultats fonctionnels et le contrôle du risque néoplasique chez les patients opérés aux CUSL depuis 1986. Méthode. Les dossiers médicaux de 166 patients consécutifs ayant bénéficié d'une CPT avec AIA manuelle pour PAF (n = 57) ou RCUH (n = 109) aux CUSL ont été passés en revue. Les données extraites comprenaient les évaluations fonctionnelles faites aux consultations de suivi, les résultats de l'analyse anatomo-pathologique de la pièce de MEA et les découvertes faites au cours de la surveillance endoscopique du réservoir iléal. Résultats. La médiane du nombre de selles dans notre série s'élève à 5,8 par 24h (El : 4,7-7,6) et à 1,0 par nuit (El: 0,5-1,8). 82% de nos patients présentent une continence diurne parfaite. 57% ont une continence parfaite la nuit et 23% présentent moins d'une fuite nocturne par semaine. 76% de nos patients ont moins d'un épisode d'impériosité par semaine et 54% n'en présentent jamais. 73% des MEA des patients opérés pour PAF montraient la présence de dysplasie ou de cancer (94% de DBG, un carcinome in situ et un carcinome invasif). Chez les patients opérés pour RCUH, une seule pièce de MEA (1,3%) contenait de la DBG. Aucun de nos patients opérés pour PAF ou RCUH n'a développé de cancer dans le réservoir ou le canal anal après des surveillances n'a pas non plus mis en évidence de polype dysplasique. Dans la PAF, 43% des patients ont développé de la DBG après un délai médian de 86 mois (El :60-128) et un patient (2,1%) a développé de la DHG 216 mois après I’AIA. Conclusions. Malgré la réalisation systématique d'une MEA chez nos patients, nos résultats fonctionnels sont aussi satisfaisants que les références trouvées dans littérature sauf en ce qui concerne la continence nocturne. Cependant, la majorité des patients signalant une altération de celle-ci ne présentent pas plus d'un épisode de fuite par semaine. L'importante prévalence de dysplasie et la présence de deux carcinomes sur les pièces de MEA de nos patients opérés pour PAF sont des arguments majeurs en faveur de sa réalisation. Dans la RCUH, la dysplasie est beaucoup plus rare. La surveillance endoscopique ne met pas en doute l'efficacité de nos MEA à l'heure actuelle. Il convient de poursuivre cette surveillance afin de garder un œil sur le développement de dysplasie dans le réservoir et l'apparition de cancer sur un ilot de muqueuse colique résiduelle. Une influence du BMI sur le développement de polypes dans le réservoir a été mise en évidence et mériterait investigation.
Proctocolectomy, Restorative --- Colitis, Ulcerative --- Adenomatous Polyposis Coli
Choose an application
Intestinal polyps --- Intestines --- Intestins --- Diseases --- Polypes --- Maladies --- Adenomatous Polyposis Coli --- Intestina Polyposis
Choose an application
Adenomatous Polyposis Coli --- Cytoskeletal Proteins --- Transcription Factors --- genetics
Choose an application
La polypose adénomateuse familiale est une maladie héréditaire dont la fréquence est de 1/10000 et le mode de transmission est dominant autosomique. Les symptômes de cette maladie apparaissent après deux ou trois décennies et les tumeurs colorectales doivent être éliminées par traitement chirurgical.
La découverte du locus lié à cette maladie à d’emblée permis à la recherche, de s’orienter vers l’établissement de méthodes de dépistage des individus ayant une copie altérée du gène (appelé gène APC) responsable, permettant d’accentuer le plus possible le diagnostic pré-symptomatique. Ces méthodes de dépistage sont effectuées parallèlement à des dépistages indirects utilisés en routine au laboratoire, il s’agit de l’étude des polymorphismes des restrictions et de l’étude des microsatellites qui mettent en évidence des polymorphismes de répétition. L’analyse des polymorphismes de restriction dans cinq familles a montré la difficulté à établir un diagnostic lorsque les sondes n’étaient pas informatives ou lorsqu’une famille ne compte qu’un seul patient atteint. Le diagnostic établi tient compte du % de recombinaison entre sondes et gène, et est de ce fait jamais totalement rassurant pour les patients « à risque » si l’informativité n’est pas située de part et d’autre du gène. Nous avons également procédé à l’étude des microsatellites pour deux de nos familles. Dans notre étude, ce sont des répétitions de doublets A-T et C-A en liaison avec le gène qui sont utilisés. Les résultats ont montré que ce type d’analyse ne permet pas toujours d’établir un diagnostic génétique précis, et doit être interprété parallèlement à l’étude des polymorphismes de restriction et au diagnostic clinique (observation des plages d’hypertrophie de l’épithélium rétinien).
Nous avons également entrepris d’analyser nos patients au niveau du gène responsable de la polypose, appliquant une méthode de détection des mutations dans ce gène. Découvert en 1991, il est constitué de 15 exons. La méthode choisie est basée sur la recherche de la modification de conformères d’ADN simple brin (méthode SSCP). Nous avons choisi d’étudier les 23 patients atteints non apparentés dans les fragments F et G de l’exon 15. Bien que plusieurs types de migration furent effectuées, aucune différence significative de conformation ne fut mise en évidence pour les sous-fragments F. Par contre, pour le fragment 15-G, quatre patients FAP ont montré des modifications de mobilité électro-phorétique bien visibles. Deux patients FAP semblent présenter des modifications identiques. Toutes les modifications se sont révélées être transmises de façon mendélienne dans les 4 familles respectives, ce qui a pu mener à établir un diagnostic définitif chez tous les patients « à risque ». Il s’est finalement avéré que les bandes obtenues par détection ne sont pas dues à des changements de conformation de l’ADN simple brin ; il s’agit d’hétéro duplex formé lors de la réaction d’amplification.
Le séquençage direct après amplification a démontré que deux des quatre patients portent bien une mutation à l’état hétérozygote, une double séquence ayant été révélée. La lecture de cette séquence fut difficile ; elle a permis de localiser l’altération au codon 1309 du gène APC, mais non d’identifier avec certitude la nature des mutations respectives.
Adenomatous Polyposis Coli --- Genes, APC --- Antigens, Neoplasm --- Genetics, Biochemical --- Medical Laboratory Science
Choose an application
It is with great pleasure that we present to you this Special Issue of Medical Sciences. In this issue, we present a comprehensive and contemporary review of the medical comorbidities that contribute to chronic rhinosinusitis, and, conversely, how our interventions as otolaryngologists can impact those systemic conditions. Our understanding of chronic rhinosinusitis has evolved tremendously over the last two decades. As we have learned, chronic rhinosinusitis—a chronic inflammatory condition of the nasal cavity and paranasal sinuses—is often a local inflammatory response to a systemic or mucosal disorder. The underlying systemic medical conditions not only influence the presentation and diagnosis of chronic rhinosinusitis, but also modify the patients’ response to medical and surgical interventions. Chronic rhinosinusitis associated with cystic fibrosis, for example, is a disorder quite distinct from that associated with aspirin-exacerbated respiratory disease. A clear understanding of the nuances that distinguish these unique and challenging disorders is critical for the practicing otolaryngologist. Equally important, however, is a clear understanding of the powerful benefits that our interventions as otolaryngologists can have for our patients’ rhinologic and systemic health. Knowing that our rhinologic interventions might spare an asthma patient a trip to an emergency room or reduce lung infections in a cystic fibrosis patient makes this a very exciting time to be a rhinologist. We hope you enjoy this Special Issue of Medical Sciences.
n/a --- AERD --- pediatric --- adenoidectomy --- chronic rhino sinusitis --- cystic fibrosis --- biofilm --- nasal polyps --- aspirin exacerbated respiratory disease --- eosinophilia --- eosinophil --- adenoiditis --- nasal poly --- endoscopic sinus surgery --- aspirin desensitization --- central compartment atopic disease --- medial maxillectomy --- allergy --- diagnosis --- adenoids --- asthma --- allergic fungal rhinosinusitis --- nasal polyposis --- Samter’s Triad --- medical management --- sinus surgery --- chronic rhinosinusitis --- sinusitis --- allergic rhinitis --- rhinosinusitis --- polyposis --- hyposmia --- Samter's Triad
Choose an application
The initial identification of the Adenomatous polyposis coli (Apc) gene as the site of mutations in familial adenomatous polyposis (FA P) was described in 1992. A causal relationship between Apc mutations and intestinal tract tumours was confirmed three years later with the establishment of the Min mouse model. These mice are heterozygous for Apc and develop numerous intestinal tumours that mimic FA P. Subsequently, Apc has emerged as the most commonly mutated gene in colorectal cancer with reports varying between 50-80 per cent of sporadic tumours carrying such mutations. The search for how m
Adenomatous Polyposis Coli Protein. --- Adenomatous Polyposis Coli. --- Colon (Anatomy) -- Cancer. --- Colorectal Neoplasms -- Metabolism. --- Genes, APC. --- Tumor suppressor proteins. --- Colon (Anatomy) --- Tumor suppressor proteins --- Adenomatous Polyposis Coli --- Colorectal Neoplasms --- Genes, APC --- Metabolism --- Adenomatous Polyposis Coli Protein --- Intestinal Polyposis --- Intestinal Neoplasms --- Colonic Neoplasms --- Neoplastic Syndromes, Hereditary --- Colonic Diseases --- Metabolic Phenomena --- Cytoskeletal Proteins --- Genes, Tumor Suppressor --- Tumor Suppressor Proteins --- Rectal Diseases --- Adenomatous Polyps --- Proteins --- Neoplasm Proteins --- Intestinal Diseases --- Neoplasms --- Genes, Neoplasm --- Phenomena and Processes --- Gastrointestinal Neoplasms --- Genes, Recessive --- Adenoma --- Genetic Diseases, Inborn --- Gastrointestinal Diseases --- Digestive System Neoplasms --- Genes --- Diseases --- Neoplasms, Glandular and Epithelial --- Congenital, Hereditary, and Neonatal Diseases and Abnormalities --- Amino Acids, Peptides, and Proteins --- Chemicals and Drugs --- Digestive System Diseases --- Genome Components --- Neoplasms by Site --- Neoplasms by Histologic Type --- Genome --- Genetic Structures --- Genetic Phenomena --- Oncology --- Medicine --- Health & Biological Sciences --- Cancer --- Cancer. --- Antioncoproteins --- Growth suppressor proteins --- Metastasis suppressor proteins --- Colon cancer --- Colorectal cancer --- Medicine. --- Biomedicine. --- Biomedicine general. --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Antioncogenes --- Health Workforce --- Biomedicine, general.
Choose an application
Nasal rhinitis polyposis not only decreases the quality of life of affected patients, but the relationship between the upper and lower respiratory tract makes the treatment of this condition of critical importance. New research findings, as well as new technical developments, have changed the conventional medical and surgical approaches to the treatment of nasal polyposis, which has resulted in significant advances in the management of the disease. This reader-friendly and lavishly illustrated book is written by authors internationally recognized for their laboratory research and clinical practice in this field. It includes the latest information, and aims to help the reader improve the daily management of patients affected by nasal polyposis.
Nasal polyposis. --- Nasal Polyps. --- Polyposis. --- Nasal polyps --- Polyps --- Nose Diseases --- Pathological Conditions, Anatomical --- Respiratory Tract Diseases --- Otorhinolaryngologic Diseases --- Nasal Polyps --- Diseases --- Pathological Conditions, Signs and Symptoms --- Medicine --- Health & Biological Sciences --- Otorhinolaryngology --- Oncology --- Treatment --- Nasal polyps. --- Nose --- Tumors. --- Medicine. --- Internal medicine. --- Otorhinolaryngology. --- Otolaryngologic surgery. --- Pediatrics. --- Surgery. --- Medicine & Public Health. --- Head and Neck Surgery. --- General Surgery. --- Internal Medicine. --- Polyps (Pathology) --- Tumors --- Head --- Medicine, Internal --- Paediatrics --- Pediatric medicine --- Children --- Surgery, Primitive --- Ear, nose, and throat diseases --- ENT diseases --- Health and hygiene --- Operative otolaryngology --- Otolaryngologic surgery --- Surgery, Operative --- Surgery, Orificial
Choose an application
Early detection of colorectal cancers is a significant and relatively recent achievement. Persons who carry genetic mutations linked to hereditary colorectal cancer make up 20% of the patient population. With the advent of molecular genetics and the description of hereditary colorectal cancer syndromes, clinicians and genetic counselors are able to use genetic predisposition testing as an effective and important way to identify patients and families affected by inherited colorectal cancer syndromes. Hereditary Colorectal Cancer is a comprehensive collection that documents not only Familial Adenomatous Polyposis and the Lynch syndrome, but also less understood syndromes, including the Hamartomatous Polyposis Syndromes and MutYH Associated Polyposis. Internationally recognized clinicians and researchers further delve into the evolution and potential of syndromes, genes and molecular alterations that have yet to be defined. Instrumental experts in this field of discovery were carefully selected by the section editors to create this premier reference work for clinicians, scientists and researchers confronted with the treatment and management of hereditary colorectal cancer.
Medicine & Public Health. --- Oncology. --- Surgical Oncology. --- Gastroenterology. --- Medicine. --- Cancer --- Médecine --- Gastroentérologie --- Cancérologie --- Surgery. --- Chirurgie --- Colon (Anatomy) --- Genetic disorders. --- Rectum --- Colorectal Neoplasms --- Adenomatous Polyposis Coli. --- Colorectal Neoplasms, Hereditary Nonpolyposis. --- Genetic Counseling. --- Genetic aspects. --- genetics. --- Colon (Anatomy) -- Cancer. --- Rectum -- Cancer. --- Genetic disorders --- Neoplastic Syndromes, Hereditary --- Intestinal Neoplasms --- Colonic Neoplasms --- Rectal Diseases --- Adenomatous Polyps --- Biology --- Intestinal Polyposis --- Genetic Services --- Colonic Diseases --- DNA Repair-Deficiency Disorders --- Genetics, Medical --- Intestinal Diseases --- Metabolic Diseases --- Gastrointestinal Neoplasms --- Health Services --- Adenoma --- Neoplasms --- Genetic Diseases, Inborn --- Biological Science Disciplines --- Adenomatous Polyposis Coli --- Colorectal Neoplasms, Hereditary Nonpolyposis --- Genetic Counseling --- Genetics --- Neoplasms, Glandular and Epithelial --- Gastrointestinal Diseases --- Digestive System Neoplasms --- Congenital, Hereditary, and Neonatal Diseases and Abnormalities --- Diseases --- Health Care Facilities, Manpower, and Services --- Nutritional and Metabolic Diseases --- Natural Science Disciplines --- Digestive System Diseases --- Neoplasms by Histologic Type --- Health Care --- Neoplasms by Site --- Disciplines and Occupations --- History & Archaeology --- Medicine --- Health & Biological Sciences --- Oncology --- History - General --- Genetic aspects --- Cancer. --- Congenital diseases --- Disorders, Genetic --- Disorders, Inherited --- Genetic diseases --- Hereditary diseases --- Inherited diseases --- Colorectal cancer --- Rectal cancer --- Colon cancer --- Surgical oncology. --- Medical genetics --- Oncology . --- Oncologic surgery --- Oncological surgery --- Surgical oncology --- Tumors --- Internal medicine --- Digestive organs --- Excision --- Treatment --- Gastroenterology .
Choose an application
Nowadays, we are dealing more frequently with the entity of large intestine polyps, as endoscopy and bowel cancer screening programmes are rapidly expanding. Often a single polyp is involved, but more complex situations are also encountered, including the well-defined pattern of polyposis. These situations can fall into a gray area, not only for diagnosis, but also for the correct treatment and follow-up. New developments in pathophysiology and treatment options are leading to new questions. This handbook aims to offer a integrated approach for all physicians (doctors) who deal with these issues, by presenting up-to-date discussion from genetics through treatment, to implications of genetic counseling. It will also help specialists to offer more "evidence-based" treatments, by implementing the best clinical individual judgement informed by the best current scientific evidence.
Colon (Anatomy) -- Cancer. --- Colonic Polyps. --- Intestinal polyps -- Physiology, Pathological. --- Intestinal polyps. --- Rectal Neoplasms. --- Rectum -- Cancer. --- Intestinal Diseases --- Polyps --- Gastrointestinal Diseases --- Pathological Conditions, Anatomical --- Digestive System Diseases --- Pathological Conditions, Signs and Symptoms --- Diseases --- Intestinal Polyposis --- Intestinal Polyps --- Surgery & Anesthesiology --- Medicine --- Health & Biological Sciences --- Oncology --- Surgery - General and By Type --- Intestinal polyps --- Polyps (Pathology) --- Genetic aspects. --- Polypi (Pathology) --- Medicine. --- Gastroenterology. --- Pathology. --- Rectum --- Surgical oncology. --- Medicine & Public Health. --- Colorectal Surgery. --- Surgical Oncology. --- Surgery. --- Tumors --- Intestines --- Colon (Anatomy) --- Disease (Pathology) --- Medical sciences --- Medicine, Preventive --- Cancer --- Oncologic surgery --- Oncological surgery --- Surgical oncology --- Internal medicine --- Digestive organs --- Excision --- Treatment --- Rectum—Surgery . --- Gastroenterology .
Choose an application
Colorectal Neoplasms, Hereditary Nonpolyposis --- Duodenal Neoplasms --- Colectomy --- Adenomatous Polyposis Coli --- Decision Support Techniques. --- Analysis, Decision --- Clinical Prediction Rule --- Decision Aids --- Decision Support Technics --- Decision Analysis --- Decision Modeling --- Models, Decision Support --- Aid, Decision --- Aids, Decision --- Analyses, Decision --- Clinical Prediction Rules --- Decision Aid --- Decision Analyses --- Decision Support Model --- Decision Support Models --- Decision Support Technic --- Decision Support Technique --- Model, Decision Support --- Modeling, Decision --- Prediction Rule, Clinical --- Prediction Rules, Clinical --- Rule, Clinical Prediction --- Rules, Clinical Prediction --- Technic, Decision Support --- Technics, Decision Support --- Technique, Decision Support --- Techniques, Decision Support --- Clinical Decision-Making --- Decision Making --- Decision Making, Organizational --- drug therapy. --- surgery. --- mortality. --- complications. --- Theses --- 681.3*D3 --- 681.3*D3 Programming languages --- Programming languages --- Decision Support Techniques --- drug therapy --- surgery --- mortality --- complications
Listing 1 - 10 of 10 |
Sort by
|